---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-100119"
form_type: "8-K"
ticker: "MDAI"
cik: "0001833498"
company_name: "Spectral AI, Inc."
filed_at: "2026-09-15T20:03:22+00:00"
generated_at: "2026-09-15T20:05:18.075852+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Spectral AI posts investor presentation: $250M+ gov funding, UKCA approval, FDA De Novo in wound-care AI

## Summary
- Posted updated investor presentation Sept 14, 2026 highlighting DeepView AI+multispectral imaging platform for wound care.
- Cites 13-year milestone track record backed by $250M+ in non-dilutive government funding from 2013-2026.
- Regulatory progress includes UKCA approval and FDA De Novo pathway; DeepView supports multiple indications.
- DeepView predicts wound healing in seconds during initial patient visit; company prioritizing profitable markets for near-term commercialization.
- Extensive patent portfolio, trade secrets and truthed images cited as competitive barriers.

## SEC filing metadata
- accession: 0001213900-26-100119
- form_type: 8-K
- ticker: MDAI
- cik: 0001833498
- company_name: Spectral AI, Inc.
- filed_at: 2026-09-15T20:03:22+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1833498/000121390026100119/0001213900-26-100119-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1833498/000121390026100119/ea0305581-8k_spectral.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-100119
- JSON: https://secwatch.observer/filing/0001213900-26-100119.json
- Plain text: https://secwatch.observer/filing/0001213900-26-100119.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.